Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lipocine ROE 2012-2025 | LPCN

Current and historical return on equity (ROE) values for Lipocine (LPCN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Lipocine ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-06-30 $0.00B $0.02B -21.05%
2025-03-31 $-0.01B $0.02B -25.00%
2024-12-31 $0.00B $0.02B 4.71%
2024-09-30 $0.00B $0.02B -14.29%
2024-06-30 $-0.01B $0.02B -36.78%
2024-03-31 $-0.01B $0.02B -37.89%
2023-12-31 $-0.02B $0.02B -66.02%
2023-09-30 $-0.02B $0.02B -57.14%
2023-06-30 $-0.01B $0.03B -35.56%
2023-03-31 $-0.01B $0.03B -30.14%
2022-12-31 $-0.01B $0.04B -25.64%
2022-09-30 $0.00B $0.04B 12.05%
2022-06-30 $0.00B $0.04B 9.94%
2022-03-31 $0.00B $0.04B 0.00%
2021-12-31 $0.00B $0.05B 0.00%
2021-09-30 $-0.02B $0.03B -57.14%
2021-06-30 $-0.02B $0.04B -70.37%
2021-03-31 $-0.02B $0.04B -84.71%
2020-12-31 $-0.02B $0.02B -168.00%
2020-09-30 $-0.02B $0.02B -185.37%
2020-06-30 $-0.02B $0.01B -211.76%
2020-03-31 $-0.02B $0.01B -193.55%
2019-12-31 $-0.01B $0.01B -129.73%
2019-09-30 $-0.01B $0.01B -120.00%
2019-06-30 $-0.01B $0.01B -100.00%
2019-03-31 $-0.01B $0.01B -91.67%
2018-12-31 $-0.01B $0.01B -84.62%
2018-09-30 $-0.01B $0.01B -83.87%
2018-06-30 $-0.02B $0.01B -86.49%
2018-03-31 $-0.02B $0.02B -89.41%
2017-12-31 $-0.02B $0.02B -90.32%
2017-09-30 $-0.02B $0.02B -76.00%
2017-06-30 $-0.02B $0.03B -65.38%
2017-03-31 $-0.02B $0.03B -61.82%
2016-12-31 $-0.02B $0.03B -62.81%
2016-09-30 $-0.02B $0.03B -61.31%
2016-06-30 $-0.02B $0.03B -61.94%
2016-03-31 $-0.02B $0.04B -50.00%
2015-12-31 $-0.02B $0.04B -43.90%
2015-09-30 $-0.02B $0.05B -45.95%
2015-06-30 $-0.02B $0.05B -45.45%
2015-03-31 $-0.02B $0.02B -63.16%
2014-12-31 $-0.02B $0.03B -61.07%
2014-09-30 $-0.02B $0.03B -53.33%
2014-06-30 $-0.02B $0.03B -48.72%
2014-03-31 $-0.01B $0.04B -42.62%
2013-12-31 $-0.01B $0.05B -44.44%
2013-09-30 $0.00B $0.04B 0.00%
2013-06-30 $0.00B $0.00B 160.00%
2013-03-31 $0.00B $0.00B 240.00%
2012-12-31 $0.00B $0.01B 320.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.011B
Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $69.605B 26.77
Zoetis (ZTS) United States $67.506B 24.49
Daiichi Sankyo, - (DSNKY) Japan $48.761B 24.99
Takeda Pharmaceutical (TAK) Japan $48.238B 9.84
BeOne Medicines - (ONC) Switzerland $34.998B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.281B 0.00
Summit Therapeutics (SMMT) United States $19.529B 0.00
Merck (MKKGY) Germany $16.730B 10.88
Shionogi (SGIOY) Japan $14.921B 14.95
United Therapeutics (UTHR) United States $14.168B 12.26
Neurocrine Biosciences (NBIX) United States $13.205B 39.39
Orion OYJ (ORINY) Finland $11.245B 27.10
IPSEN (IPSEY) France $10.601B 0.00
Eisai (ESAIY) $9.193B 10.37
Madrigal Pharmaceuticals (MDGL) United States $8.691B 0.00
Corcept Therapeutics (CORT) United States $7.561B 63.50
Grifols, S.A (GRFS) Spain $7.274B 0.00
Ionis Pharmaceuticals (IONS) United States $6.922B 0.00
Stevanato Group S.p.A (STVN) Italy $6.841B 40.34
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.402B 18.55
Soleno Therapeutics (SLNO) United States $3.619B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.908B 13.82
NewAmsterdam Pharma (NAMS) Netherlands $2.861B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.801B 0.00
Hypermarcas (HYPMY) Brazil $2.597B 19.52
Catalyst Pharmaceuticals (CPRX) United States $2.476B 8.29
Centessa Pharmaceuticals (CNTA) United Kingdom $2.356B 0.00
Ocular Therapeutix (OCUL) United States $2.142B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.759B 0.00
Dyne Therapeutics (DYN) United States $1.754B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.609B 23.96
Guardian Pharmacy Services (GRDN) United States $1.571B 0.00
Harrow (HROW) United States $1.418B 0.00
Ardelyx (ARDX) United States $1.400B 0.00
ARS Pharmaceuticals (SPRY) United States $1.387B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.309B 0.00
Evotec AG (EVO) Germany $1.307B 0.00
Collegium Pharmaceutical (COLL) United States $1.203B 6.57
Xeris Biopharma Holdings (XERS) United States $1.188B 0.00
Enliven Therapeutics (ELVN) United States $1.170B 0.00
Cronos Group (CRON) Canada $0.969B 0.00
Akebia Therapeutics (AKBA) United States $0.825B 0.00
ProKidney (PROK) United States $0.743B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.719B 7.41
Amylyx Pharmaceuticals (AMLX) United States $0.712B 0.00
Theravance Biopharma (TBPH) United States $0.685B 56.71
KalVista Pharmaceuticals (KALV) United States $0.666B 0.00
Siga Technologies (SIGA) United States $0.639B 7.89
Elite Pharmaceuticals (ELTP) United States $0.615B 0.00
Relay Therapeutics (RLAY) United States $0.598B 0.00
Bioventus (BVS) United States $0.594B 14.36
Organogenesis (ORGO) United States $0.581B 0.00
Oruka Therapeutics (ORKA) United States $0.571B 0.00
Tourmaline Bio (TRML) United States $0.569B 0.00
Xencor (XNCR) United States $0.557B 0.00
USANA Health Sciences (USNA) United States $0.554B 11.36
Savara (SVRA) United States $0.527B 0.00
Nektar Therapeutics (NKTR) United States $0.522B 0.00
Zevra Therapeutics (ZVRA) United States $0.516B 0.00
Esperion Therapeutics (ESPR) United States $0.423B 0.00
Nanobiotix S.A (NBTX) France $0.422B 0.00
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.351B 0.00
4D Molecular Therapeutics (FDMT) United States $0.340B 0.00
Aldeyra Therapeutics (ALDX) United States $0.326B 0.00
Larimar Therapeutics (LRMR) United States $0.323B 0.00
Altimmune (ALT) United States $0.314B 0.00
Nature's Sunshine Products (NATR) United States $0.290B 18.93
AleAnna (ANNA) United States $0.282B 0.00
Galectin Therapeutics (GALT) United States $0.250B 0.00
OmniAb (OABI) United States $0.247B 0.00
Lyell Immunopharma (LYEL) United States $0.209B 0.00
Aclaris Therapeutics (ACRS) United States $0.200B 0.00
Heron Therapeutics (HRTX) United States $0.199B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Korro Bio (KRRO) United States $0.185B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.183B 28.25
Innate Pharma SA (IPHYF) France $0.173B 0.00
Lexeo Therapeutics (LXEO) United States $0.163B 0.00
Journey Medical (DERM) United States $0.163B 0.00
MEI Pharma (MEIP) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.148B 0.00
Profound Medical (PROF) Canada $0.143B 0.00
Achieve Life Sciences (ACHV) Canada $0.136B 0.00
Inhibikase Therapeutics (IKT) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.124B 0.00
Avalo Therapeutics (AVTX) United States $0.119B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.110B 0.00
Liminatus Pharma (LIMN) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.102B 0.00
Dominari Holdings (DOMH) United States $0.100B 0.00
Champions Oncology (CSBR) United States $0.096B 21.78
Surrozen (SRZN) United States $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.090B 0.00
VAXART, INC (VXRT) United States $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
BioNxt Solutions (BNXTF) Canada $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Metagenomi (MGX) United States $0.072B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Gain Therapeutics (GANX) United States $0.064B 0.00
DURECT (DRRX) United States $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Wellgistics Health (WGRX) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Rafael Holdings (RFL) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Karyopharm Therapeutics (KPTI) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 27.91
FibroGen (FGEN) United States $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Mural Oncology (MURA) Ireland $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.026B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.16
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.65
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00